Ryan Earle
Family · Jacksonville, TXNPI 1699319384
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 192 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 18.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $745 and has fallen 54.0% since, to $343 in 2025.
Across 192 payments — averaging $13.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$476
- GSK$465
- Novo Nordisk$318
- Boehringer Ingelheim$282
- Bayer$234
- Merck$224
- plus $606 from 16 others
What the payments were for
- Food & beverage$2,606100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 43 | $476 |
| GSK | 50 | $465 |
| Novo Nordisk | 17 | $318 |
| Boehringer Ingelheim | 21 | $282 |
| Bayer | 14 | $234 |
| Merck | 14 | $224 |
| Pfizer | 6 | $199 |
| Mylan Specialty L.p. | 7 | $98 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $59 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $28 |
| Kowa Pharmaceuticals America, Inc. | 2 | $25 |
| AbbVie | 2 | $24 |
| Corcept Therapeutics | 1 | $21 |
| Amarin Pharma, Inc. | 1 | $18 |
| Pacira Pharmaceuticals Incorporated | 1 | $16 |
| AstraZeneca | 1 | $16 |
| Exact Sciences | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
| Lundbeck LLC | 1 | $14 |
| Genentech USA, Inc. | 1 | $12 |
| Orthofix Medical, Inc. | 1 | $11 |
How this compares
$2,606 in reported general payments places this provider in the 85th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 14 | $15,546 |
| JardianceEmpagliflozin | 13 | $14,972 |
| TrulicityDulaglutide | 13 | $12,015 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 14 | $8,794 |
| EliquisApixaban | 12 | $6,721 |
| Cefdinir | 62 | $1,005 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 25 | $762 |
| Doxycycline Hyclate | 93 | $674 |
| Omeprazole | 29 | $353 |
| Valsartan | 14 | $289 |
| Pantoprazole Sodium | 25 | $286 |
| Gabapentin | 27 | $264 |
| Bumetanide | 12 | $222 |
| Cephalexin | 42 | $220 |
| Losartan Potassium | 23 | $216 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $318 | $15,54614 claims |
| Boehringer IngelheimJardiance | $282 | $14,97213 claims |
| Lilly USA, LLCTrulicity | $476 | $12,01513 claims |
| GSKTrelegy Ellipta | $465 | $8,79414 claims |
| PfizerEliquis | $199 | $6,72112 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 15,456 family providers in Texas.
Other family in Jacksonville
- David WeirDallas$959K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
- Angela AchaPflugerville$174K
- Susan BowlinIrving$164K
- Stephanie RodriguezCorpus Christi$159K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.